RT Journal Article
SR Electronic
A1 Mann, Kate
T1 LIRA-ADD2BASAL: Liraglutide Added to Basal Insulin Analogs Improves Glycemic Control
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 32
SP 13
OP 14
DO 10.1177/155989771432007
UL http://mdc.sagepub.com/content/14/32/13.abstract
AB The 2012 American Diabetes Association/European Association for the Study of Diabetes position statement for the management of hyperglycemia recommends, as 1 of the 3-drug combinations, the addition of glucagon-like peptide–1 receptor agonists to basal insulin analogs (or conversely, insulin to GLP-1 receptor agonists) after initial therapy with metformin. This article presents the results of the Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes trial [LIRA-ADD2BASAL; NCT01617434], comparing the efficacy and safety of liraglutide versus placebo when added to basal insulin analogs.